Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-13-003753

Director bought 200,000 shares

From the SEC's structured data for this filing

Trades in this filing

BROADWOOD PARTNERS LP · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2013-06-04 Purchase : show line 1 in the form +200,000 9,022,220 D
2013-06-04 Purchase : show line 2 in the form +0 9,022,220 I
Open-market purchases · 200,000 sh

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-06-04 Purchase : show line 3 in the form Option to Purchase Common Shares +50,000 $5.00 2018-06-04 50,000 50,000 D
Loading xslF345X03/p1387998.xml…